Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) poses clinical challenges due to its varied prognosis, tumor microenvironment attributes, and responses to immunotherapy. We established a novel Programmed Cell Death-related Signature (PRS) for ccRCC assessment, derived through the Least Absolute Shrinkage an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Zhang, Mingcong, Song, Lebin, Wang, Shuai, Wei, Xiyi, Shao, Wenchuan, Song, Ninghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662159/
https://www.ncbi.nlm.nih.gov/pubmed/37985807
http://dx.doi.org/10.1038/s41598-023-46577-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662159/
https://www.ncbi.nlm.nih.gov/pubmed/37985807
http://dx.doi.org/10.1038/s41598-023-46577-z

Ejemplares similares